Showing results (11-20 of 605) with videos related to
Sort By:
Pageof 61
Annual Review of Pathology|November 15, 2011
Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progressionKarl Staser, Feng-Chun Yang, D Wade ClappFrontiers in Immunology|September 25, 2023
Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant modelsRamzi Abboud, Sena Kim, Karl Staser, et al.Blood|March 18, 2010
Mast cells and the neurofibroma microenvironmentKarl Staser, Feng-Chun Yang, D Wade ClappCurrent Opinion in Hematology|June 24, 2010
Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cellsKarl Staser, Feng-Chun Yang, David W ClappCancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|July 24, 2012
The plexiform neurofibroma microenvironmentFeng-Chun Yang, Karl Staser, D Wade ClappBlood Reviews|November 15, 2017
Diabetes mellitus as a poor mobilizer conditionGian Paolo Fadini, John F DiPersioLeukemia|April 26, 2018
Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host diseaseJaebok Choi, Matthew L Cooper, Karl Staser, et al.Expert Review of Hematology|July 16, 2014
Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinicMuneera Al-Hussaini, John F DiPersioThe Journal of Clinical Investigation|January 2, 2026
Preventing graft re-JAK-tion: safer transplant conditioning enables murine islet allograft tolerance and diabetes reversalStephen P Persaud, John F DiPersioPageof 61